
SARS-CoV / SARS-CoV-2 Nucleoprotein / NP Antibody, Rabbit PAb, Antigen Affinity Purified General Information
SARS-CoV / SARS-CoV-2 Nucleoprotein / NP Antibody, Rabbit PAb, Antigen Affinity Purified Validated Applications
Application | Dilution |
---|---|
WB | 1:1000-1:5000 |
ELISA | 1:5000-1:10000 |
SARS-CoV / SARS-CoV-2 Nucleoprotein / NP Antibody, Rabbit PAb, Antigen Affinity Purified Images

Anti-SARS-NP rabbit polyclonal antibody at 1:2000 dilution.
Lane A: SARS-CoV NP Protein (Cat#40143-V08B) (30ng)
Lane B: SARS-CoV NP Protein (Cat#40143-V08B) (5ng)
Lane C: SARS-CoV-2 (2019-nCoV) NP Protein (Cat#40588-V08B) (30ng)
Lane D: SARS-CoV-2 (2019-nCoV) NP Protein (Cat#40588-V08B) (5ng)
Secondary
Goat Anti-Rabbit IgG (H+L)/HRP at 1/10000 dilution.
Developed using the ECL technique.
Performed under reducing conditions.
SARS-CoV / SARS-CoV-2 Nucleoprotein / NP Antibody, Rabbit PAb, Antigen Affinity Purified: Synonyms
Coronavirus Nucleocapsid Background Information
- 1.Van Boheemen S, et al. (2012),MBio. 3(6):e00473-12.
- Bisht H. et al., 2004,Proc Natl Acad Sci. 101 (17): 6641-6.
- Li W. et al., 2005,Science.309 (5742): 1864-8.
- Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate modelAuthorRockx, B;Kuiken, T;Herfst, S;Bestebroer, T;Lamers, MM;Oude Munnink, BB;de Meulder, D;van Amerongen, G;van den Brand, J;Okba, NMA;Schipper, D;van Run, P;Leijten, L;Sikkema, R;Verschoor, E;Verstrepen, B;Bogers, W;Langermans, J;Drosten, C;Fentener van Vlissingen, M;Fouchier, R;de Swart, R;Koopmans, M;Haagmans, BL;Year2020JournalScienceApplicationIHCPubMed ID: 32303590FoldedExpand
- Evidence for gastrointestinal infection of SARS-CoV-2AuthorXiao, F;Tang, M;Zheng, X;Liu, Y;Li, X;Shan, H;Year2020JournalGastroenterologyPubMed ID: 32142773FoldedExpand
- Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in ChinaAuthorSu, H;Yang, M;Wan, C;Yi, LX;Tang, F;Zhu, HY;Yi, F;Yang, HC;Fogo, AB;Nie, X;Zhang, C;Year2020JournalKidney Int.ApplicationIFPubMed ID: 32327202FoldedExpand
- Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and TreatmentAuthorSun, J;Zhuang, Z;Zheng, J;Li, K;Wong, R;Liu, D;Huang, J;He, J;Zhu, A;Zhao, J;Li, X;Xi, Y;Chen, R;Alshukairi, A;Chen, Z;Zhang, Z;Chen, C;Huang, X;Li, F;Lai, X;Chen, D;Wen, L;Zhuo, J;Zhang, Y;Wang, Y;Huang, S;Dai, J;Shi, Y;Zheng, K;Leidinger, M;Chen, J;Li, Y;Zhong, N;Meyerholz, D;McCray, P;Perlman, S;Zhao, J;Year2020JournalCellApplicationFFAFoldedExpand
If you couldn"t find the specific citation, you can:
- Find All Citations
- Submit a CitationGet a Publication Reward
- Leave Us a Message
Recombinant Antibody Production Service
High-throughput Recombinant Antibody Production
Large-scale Antibody Production
Antibody Development Service
Rabbit MAb Production Service
Mouse MAb Production Service
Rabbit PAb Production Service
Phospho-Specific Antibody
Anti-Idiotype Antibody
Fast Antibody Development Service
Mouse MAb
Rabbit PAb
More Antibody Production Service
Hybridoma Antibody Production
Chimeric Antibody
Antibody Fragment
Bispecific Antibody
We also have Immunoassay Service. Click to see more.